Back to Search
Start Over
Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
- Source :
-
Pathology, research and practice [Pathol Res Pract] 2022 Jun; Vol. 234, pp. 153937. Date of Electronic Publication: 2022 May 06. - Publication Year :
- 2022
-
Abstract
- Background: The differential diagnosis between flat urothelial lesions [reactive urothelial atypia (RUA), atypia of unknown significance (AUS), urothelial dysplasia (UD) and carcinoma in situ (CIS)] has relevant prognostic and therapeutic implications. This crucial distinction could be very challenging but it is currently performed on hematoxylin and eosin (H&E) slides, with a great amount of partially discordant and/or not conclusive findings of the potential adjunctive role of immunohistochemistry. Herein, we tested double staining (DS) for p53/CK20 to verify if p53(+) cells, CK20(+) cells and double-positive cells (DPCs) are differentially expressed among these lesions and if p53/CK20 could be a useful tool in this diagnostic setting.<br />Methods: We tested 50, 9, 36 and 29 consecutive and retrospectively enrolled cases of RUA, AUS, UD and CIS, respectively. p53(+) cells, CK20(+) cells and DPCs were evaluated and compared by adopting the appropriate statistic tests (Mann-Whitney U and Kruskal-Wallis tests).<br />Results: We found that p53(+) cells (p = 0.000), CK20(+) cells (p = 0.000) and DPCs (p = 0.000) showed statistically significant differences among the different flat urothelial lesions. Besides, when dichotomized, both CIS and RUA are easily differentiable from their histological mimickers adopting all these markers; by contrast, AUS and UD did not reach statistically significant differences able to differentiate them from each other [p53(+) cells, p = 0.123; CK20(+) cells, p = 0.567; DPCs, p = 0.409], except if compared to CIS [AUS VS CIS: p53(+) cells, p = 0.013; CK20(+) cells, p = 0.000; DPCs, p = 0.000; UD vs CIS: p53(+) cells, p = 0.000; CK20(+) cells, p = 0.000; DPCs, p = 0.000].<br />Conclusions: p53(+) cells, CK20(+) cells and DPCs are differently expressed by flat urothelial lesions and p53/CK20 could be a time- and money-saving tool for the appropriate management of these lesions if applied to a routine scenario.<br /> (Copyright © 2022 Elsevier GmbH. All rights reserved.)
- Subjects :
- Biomarkers, Tumor analysis
Biomarkers, Tumor metabolism
Coloring Agents
Humans
Keratin-20 analysis
Keratin-20 metabolism
Retrospective Studies
Staining and Labeling
Tumor Suppressor Protein p53 analysis
Tumor Suppressor Protein p53 metabolism
Carcinoma in Situ diagnosis
Carcinoma in Situ metabolism
Carcinoma in Situ pathology
Carcinoma, Transitional Cell diagnosis
Carcinoma, Transitional Cell metabolism
Carcinoma, Transitional Cell pathology
Urinary Bladder Neoplasms diagnosis
Urinary Bladder Neoplasms metabolism
Urinary Bladder Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1618-0631
- Volume :
- 234
- Database :
- MEDLINE
- Journal :
- Pathology, research and practice
- Publication Type :
- Academic Journal
- Accession number :
- 35561522
- Full Text :
- https://doi.org/10.1016/j.prp.2022.153937